This inventor holds 4 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 4 EPO patents. Top assignees: Fraunhofer-Gesellschaft Zur Foerderung Der Angewandten Forschung E.v., Novartis Ag, Rheinisch-Westfaelische Technische Hochschule Aachen. Active years: 2013-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Koln, DE (2015)
- Aachen, DE (2013 - 2018)
- Giessen, DE (2018)
Company Filing History:
3 out of 4,924 
1 out of 3,978 
1 out of 16 
Years Active: 2013-2018
Title: Mehmet Kemal Tur: Innovator in Cancer Treatment
Introduction
Mehmet Kemal Tur is a prominent inventor based in Giessen, Germany. He has made significant contributions to the field of cancer treatment, particularly in targeting acute myeloid leukemia (AML) cells. With a total of 4 patents to his name, Tur's work is paving the way for innovative therapies in oncology.
Latest Patents
Among his latest patents is a fusion protein designed to target and treat acute myeloid leukemia cells. This polypeptide binds to the surface of AML blast cells and is internalized upon binding, offering a novel approach to treatment. Additionally, he has developed photoimmunoconjugates for use in photodynamic therapy, which comprise compounds that enhance the effectiveness of light-based treatments for cancer.
Career Highlights
Throughout his career, Tur has worked with esteemed organizations such as the Fraunhofer Gesellschaft zur Förderung der angewandten Forschung e.V. and the Rheinisch-Westfälische Technische Hochschule Aachen. His experience in these institutions has allowed him to collaborate on groundbreaking research and development projects.
Collaborations
Tur has collaborated with notable colleagues, including Stefan Barth and Jenny Fitting. Their combined expertise has contributed to the advancement of innovative solutions in cancer therapy.
Conclusion
Mehmet Kemal Tur's work exemplifies the impact of innovation in medical science, particularly in the fight against cancer. His patents and collaborations highlight his commitment to improving treatment options for patients with acute myeloid leukemia.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile